Price/Volume Surge: IDM Pharma, Inc. (IDMI)
IDM Pharma, Inc. (NASDAQ: IDMI) is seeing a volume and major price surge right at the open. The company received recommendation for approval of Mifamurtide for the treatment of patients with non-metastatic, resectable osteosarcoma in Europe from the Committee for Medicinal Products for Human Use of the European Medicines Agency. The agency has issued a [...]
VS Investor RSS Feed